ARCHIVES

Cooperative Group Chairmen, OPRR Seek Agreement On Assurances

This article is from The Cancer Letter archive.

Vol. 10 No. 01 | January 6, 1984

Download PDF Visit The Full Archive

Related Articles

National Academy Of Sciences To form Cancer Policy Board At NCI’s Request

August 16, 1996

Two Phase II Trials Display Ramucirumab Potential Efficacy

October 26, 2012

FDA Committee Approves Two NDAs, Blocks One, Hears NCI Toxicology Plan

June 15, 1979

DSMB Recommends Discontinuing Phase III Perifosine Combination Trial

March 29, 2013

Amgen Replaces “Bundling” Contract With Three Separate Contracts For Growth Factors.

September 5, 2008

Final Issue Of ‘77

December 16, 1977